Ph.D., Director of Business Development, NuProbe
Biography
Nicolas Garreau de Loubresse, Ph.D., serves as Director of Business Development for NuProbe, USA. Previously, he was a Research Fellow at the Wyss Institute at Harvard University and a Business Development Fellow at Harvard Office of Technology Development. He is also the co-founder of Urania Therapeutics and inventor of Urania’s core technologies. He published first-author articles in Science and Nature, and received competitive fellowships (EMBO, HFSP) and awards (AXA-French Academy of Science).
Clinical & Research Tools Showcase:
NuProbe
NuProbe accelerates technology innovation in precision diagnostics to enable diseases to be detected, treated and cured earlier for better outcomes with lower costs.
Ultra-sensitive Biomarker Assay Development for Translational Research & Precision Medicine
- Biomarker detection strategies with best-in-class sensitivity from solid tumor and liquid biopsy
- From research use only to clinical trial; assay development and validation, clinical specimen testing, and manufacturing services
- Insights into NuProbe's assay development programs addressing challenging translational research questions
